New Key Statistics Module, Z-Score and F-Score
NAS:KYMR Key Ratios
Market Cap $ M | 2,269.64 |
Enterprise Value $ M | 1,768.67 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 5.20 |
Price/Sales | 28.08 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 78.00 |
EPS (TTM) $ | -2.52 |
Beneish M-Score | 0.67 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -19.50 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -12.05 |
EV-to-EBITDA | -12.35 |
PEG | -- |
Shares Outstanding M | 61.36 |
Net Margin (%) | -186.99 |
Operating Margin % | -210.62 |
Pre-tax Margin (%) | -186.99 |
Quick Ratio | 4.73 |
Current Ratio | 4.73 |
ROA % (ttm) | -25.10 |
ROE % (ttm) | -33.74 |
ROIC % (ttm) | -74.49 |
Dividend Yield % | -- |
Altman Z-Score | 5.73 |
KYMR Number of Guru Trades
KYMR Volume of Guru Trades
Gurus Latest Trades with NAS:KYMR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:KYMR is held by these investors
Total 2
Kymera Therapeutics Inc Insider Transactions
No Available Data
News about NAS:KYMR
Total 0- 1